PHIO

#5181
Phio Pharmaceuticals Corp. - Common Stock
0.0 1 USD
-99.03%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
0.01
0.01
Rango anual
0.01
1.35
Cambio diario
-99.03%
Variación mensual
-99.08%
Variación en los últimos 6 meses
-99.07%
Cambio anual
-99.07%
Cierres anteriores
1.1 4
Open
0.0 1
Mínimo
0.0 1
High
0.0 1
Volumen
5
Ver el calendario completo Full chart

Financials

Visión general Informes Estadísticas
Trimestre Año
Valor 202020212022202320242025 Current
Key stats
Valuation ratios
Profitability ratios
Liquidity ratios
Solvency ratios
Per share metrics

Phio Pharmaceuticals Corp. - Common Stock

Phio Pharmaceuticals Corporation is a US clinical stage biotechnology company developing its INTASYL siRNA in immuno-oncology. Formerly known as RXi Pharmaceuticals, the company's name was changed to Phio Pharmaceuticals in 2018.

Noticias